Insights from WCLC24: Ana I. Velázquez Mañana’s Key Highlights
The WCLC24 is taking place at the San Diego Convention Center from September 7 to 10, 2024.
Organized by the International Association for the Study of Lung Cancer (IASLC), this major conference is gathering leading experts, researchers, and oncologists to present and discuss the latest advancements in lung cancer research, treatment, and personalized therapies, fostering collaborative efforts towards overcoming the challenges of lung cancer.
Ana I. Velázquez Mañana, Assistant Professor of Medicine, University of California, San Francisco, shared some insights from the conference.
Challenges of implementation of novel AI pathology methods in real world settings
Excellent discussion by Sanja Dacic on the challenges of implementation of novel AI pathology methods in real world settings.
Gaps in care continue broadening with increasing costs.
Ivonescimab vs. Pembrolizumab
mPFS 11.14 vs 5.82 mo
Across all subgroups.
AE profile consistent with VGEF blockade.
Limitation of comparator pembro monotherapy arm in PD-L1 < 50% would not be current SOC.
Who benefits from adjuvant IO after neoadjuvant chemo+IO and surgery?
Exploratory analysis comparing CM816 to CM77T.
Patrick Forde Tries to answer a difficult question, who benefits from adjuvant IO after neoadjuvant chemo+IO and surgery?
Suggested benefit for perioperative approach across subgroups except those with pCR and highest difference in PD-L1 <1%
Opening plenary and warm welcome to beautiful San Diego by the WCLC24 cochairs
Sandip Patel, Linda Martin, Fabio Moraes, and Narjust Florez.
The WCLC24 Communication Workshop
Tons of excitement and new ideas from IASLC Communications Committee!
Join us now at 26B for the WCLC24 Communication Workshop.
After years of admiring and reading the work of the Boricua, Ciencias Médicas UPR grad who ‘MADE it’ – as faculty as a researcher focused on Lung Cancer screening in Latinos and Puerto Rico, who is a mentor to so many, and a champion of diversity and inclusion — I finally met him!
And best part is, Efrén J. Flores is even nicer than I imagined!
Hopeful testimony from Tomasa Ramirez
Moving and hopeful testimony from Tomasa Ramirez regarding her journey living with Lung Cancer and her desire to promote HOPE among the many patients and families affected by Lung Cancer.
Grateful to IASLC and Narjust Florez for inspiring hope and highlighting patients’ experience center stage at WCLC24.
Julie Brahmer, a pioneer in immunotherapy in Lung Cancer
HUGE Congratulations to Julie Brahmer a pioneer in immunotherapy in Lung Cancer and outstanding mentor and role model for so many of us WCLC24.
For more updates on WCLC24, visit oncodaily.com.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023